Publicaciones en las que colabora con Israel López Valero (9)

2022

  1. Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial

    Cancers, Vol. 14, Núm. 10

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells

    Theranostics, Vol. 10, Núm. 11, pp. 5120-5136

2018

  1. Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma

    Biochemical Pharmacology, Vol. 157, pp. 275-284

  2. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide

    Biochemical Pharmacology, Vol. 157, pp. 266-274

2016

  1. Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization

    Autophagy, Vol. 12, Núm. 11, pp. 2213-2229

2015

  1. Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death

    Journal of Investigative Dermatology, Vol. 135, Núm. 6, pp. 1629-1637

  2. Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation

    Cell Death and Differentiation, Vol. 22, Núm. 1, pp. 131-144

  3. TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling

    Molecular and Cellular Oncology, Vol. 2, Núm. 3